4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-20-052463
CMO and Head of R&D acquired 3,844 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PRASAD SUYASH CMO and Head of R&D | 2020-09-28 | Conversion | +3,844 | 672,589 | D | ||
| Derivatives | |||||||
| PRASAD SUYASH CMO and Head of R&D | 2020-09-28 | Conversion · Series B Preferred Stock | −3,529 | 0 | D | ||
Loading xslF345X03/doc4.xml…